Investigator Sponsored Trials (ISTs) are a beneficial method to better understand the potential risks, safety and additional uses that can improve patient health. Participating in these programs, however, can present challenges to the sponsor and
often creates a push and pull between Medical Affairs and Clinical Development, with Supply as the bridge between the two. This panel webinar brings together perspectives from Medical Affairs, Clinical Development and Supply to discuss best practices
for effectively managing ISTs.
- Bridge the gap between Medical Affairs and Clinical Development
- Gain insights how to manage and track these programs at scale
- Effectively manage supply as you move from clinical to medical affairs and beyond
This webinar will benefit professionals involved in:
- Clinical Operations
- Clinical Supply
- Medical Affairs
Director of Clinical Supply Chain, Morphic Therapeutics
Terry received her BS in Chemical Engineering at Rutgers University - College of Engineering and maintains her, Professional Engineer (P.E.) license in Pennsylvania. After restarting her career in the pharmaceutical industry, first as a ‘admin’ then as a ‘packaging technician’ at a small boutique clinical packaging site, she began working on investigator-sponsored trials at Sanofi in 2010, moving to Bayer shortly thereafter. In July 2017, Terry joined TESARO to support ISTs, EAP, and collaboration with other pharmaceutical partners, where she currently works after TESARO was acquired by GSK in 2019.
Senior Director, Client Solutions, 4G Clinical
Kathleen Greenough, Senior Director, Client Solutions at 4G Clinical, has 16 years of experience in life sciences spanning Clinical Operations, Finance, and IT. Her wide range of solutions implementation expertise includes RTSM, CTMS, trial costing tools, OLAP financial suites and patient enrollment planning. Kathleen has also spent many years as a Clinical Financial Planner and Analyst at a major biotech in Cambridge, MA, gaining a broad and deep understanding of the challenges inherent in Clinical Development. Specializing in software adoption and a frequent speaker at industry conferences, Kathleen is most in her element when working within a user community to facilitate solutions that are insightful and truly helpful.
4G Clinical is a leader in randomization and trial supply management (RTSM) and clinical supply optimization software for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. Our expert staff possesses a combination of humility, confidence, curiosity and commitment to getting things done. Most importantly, everyone at 4G Clinical is passionate about our mission of bringing crucial medicines to those who need them, faster. Learn more at www.4gclinical.com/home.